High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program

Preventive Medicine
Alexandra LuquainChristiane Mougin

Abstract

To determine the prevalence of cytological abnormalities and high risk Human PapillomaVirus (hrHPV) in cervical smears from French women aged over 65 years who attended the referent Gynecology Clinic of the Besançon University Hospital. Between 2002 and 2012, 796 French women aged 66-99 years were cotested for cytology and hrHPV by Hybrid Capture 2 (hc2). hc2-positive cases were subjected to real time PCR for specific HPV 16/18/45 genotyping. Women with normal Pap smears and positive for hrHPV were followed-up every 12 months. Cytological abnormalities were detected in more than 30% of women and cervical cancers (CC) in 2.9% of women. Benign lesions were more frequent in women aged 66-75 years while (pre)-malignant lesions were preferentially found in women over 76. The prevalence of hrHPV was 22.7%. HPV 16 was the most frequent (23.8%), followed by HPV 45 (7.7%) and HPV 18 (3.9%). The rate of hrHPV increased with the lesion severity and HPV 16 was identified in 50% of CC. Among the followed-up women, those who developed CIN3 were HPV16 positive at study entry. The study provides important estimates of the prevalence of cervical abnormalities and hrHPV positivity in a French hospital based-population over 65. Findings suggest t...Continue Reading

References

Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Nov 26, 1999·The New England Journal of Medicine·K L WallinJ Dillner
Jun 21, 2001·JAMA : the Journal of the American Medical Association·L C Walter, K E Covinsky
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Nov 6, 2003·Gynecologic Oncology·Jean Luc BrunClaude Hocké
Nov 26, 2003·International Journal of Cancer. Journal International Du Cancer·Marc F D BaayJan B Vermorken
Jan 24, 2004·Journal of Medical Screening·B E SirovichE S Fisher
Apr 28, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V DalsteinC Mougin
Jul 12, 2005·Japanese Journal of Clinical Oncology·Akiko IokaAkira Oshima
Sep 29, 2005·BMC Infectious Diseases·Maria G CenturioniClaudio A Gustavino
Jan 21, 2006·Cancer Research·Philip E CastleRobert D Burk
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Silvia FranceschiNubia Muñoz
Jul 27, 2007·Preventive Medicine·Andrea R SpenceEduardo L Franco
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Jean-Luc PrétetUNKNOWN EDITH study group
Oct 19, 2007·The New England Journal of Medicine·Marie-Hélène MayrandUNKNOWN Canadian Cervical Cancer Screening Trial Study Group
May 1, 2008·Journal of the National Cancer Institute·Bengt AndraeSven Törnberg
May 29, 2008·Journal of General Internal Medicine·Alison J HuangGeorge F Sawaya
Jun 13, 2008·Revue D'épidémiologie Et De Santé Publique·A BelotM Velten
Nov 4, 2008·Obstetrics and Gynecology·Stacy Tessler LindauJeanne A Jordan
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 8, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynJ Ferlay
May 9, 2012·Gynecologic Oncology·Helen DinkelspielPhilip E Castle
Jun 8, 2013·Cancer Causes & Control : CCC·Aruna KamineniNoel S Weiss
Jul 31, 2013·Journal of Virological Methods·Elise JacquinJean-Luc Prétet
May 13, 2014·American Journal of Obstetrics and Gynecology·Mona SaraiyaElizabeth R Unger
Dec 3, 2014·Maturitas·Laurie Elit
Mar 31, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Miriam ElfströmJoakim Dillner

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology
Li-hua BianHong-tu Liu
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
Bruce R AllanAnna-Lise Williamson
© 2021 Meta ULC. All rights reserved